Header

Novartis Financial Results – Q3 2021

Novartis announced the company’s financial results for the third quarter of 2021.

 

Novartis Gene Therapies Global Managed Access Program

Novartis Gene Therapies recommits to Global Managed Access Program for 2021 so that children around the world can benefit from SMA treatment who otherwise would not have access to Zolgensma.

Read More